SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-12-495503
Filing Date
2012-12-07
Accepted
2012-12-07 17:01:06
Documents
5
Effectiveness Date
2012-12-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d447070ds8.htm S-8 47658
2 SYNAGEVA BIOPHARMA CORP 2005 STOCK PLAN, AS AMENDED d447070dex43.htm EX-4.3 72394
3 OPINION OF ROPES & GRAY, LLP d447070dex51.htm EX-5.1 4785
4 CONSENT OF PRICEWATERHOUSECOOPERS, LLP d447070dex231.htm EX-23.1 1439
5 GRAPHIC g447070g65e46.jpg GRAPHIC 2314
  Complete submission text file 0001193125-12-495503.txt   130734
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-185349 | Film No.: 121250803
SIC: 2836 Biological Products, (No Diagnostic Substances)